As SK Bioscience's COVID-19 vaccine SKY Covione received an item permit today (29th), Korea has become a country with both COVID-19 treatments and vaccines along with Celltrion's COVID-19 treatment Regkirona.
Oh Yu-kyung, Minister of Food and Drug Safety announced on June 29 that it decided to grant item permission on condition that SKY Covione, a COVID-19 vaccine developed by SK Bioscience and applied for permission to manufacture, sell, and item, submit a final clinical trial result report.

SKY Covione is a COVID-19 vaccine that induces an immune response by administering antigen proteins made using gene recombination technology. This product was licensed for the purpose of preventing COVID-19